Related Experiment Videos
Antiviral agents. Chemical modifications of a disulfide antibiotic, acetylaranotin
Journal of Medicinal Chemistry
|August 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
N-phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity.
Journal of medicinal chemistry·1993
Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses.
International journal of immunopharmacology·1987
Identification of human urinary mitoxantrone metabolites.
Cancer research·1986
Design of anticancer drugs using modeling techniques.
Annals of the New York Academy of Sciences·1985
Synthesis of 3,6-bis(aminoalkoxy)acridines and their effect on the immune System.
Journal of medicinal chemistry·1983
Antitumor agents. 2. Bisguanylhydrazones of anthracene-9,10-dicarboxaldehydes.
Journal of medicinal chemistry·1982
Structural and Mechanistic Studies of ADEPs Yield Potent Antibacterials and a Drug Formulation Strategy for Tuberculosis.
Journal of medicinal chemistry·2026
A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.
Journal of medicinal chemistry·2026
From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis.
Journal of medicinal chemistry·2026
Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria.
Journal of medicinal chemistry·2026
Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.
Journal of medicinal chemistry·2026
Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.
Journal of medicinal chemistry·2026
Next-generation nanocrystals of phytochemicals: overcoming bioavailability challenges and enabling targeted therapeutics.
Chemical communications (Cambridge, England)·2026